7Baggers
 All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy  Yahoo Finance Tue, 30 Sep 2025 16:00:04 GMT
 Are Medical Stocks Lagging Adagene (ADAG) This Year?  Yahoo Finance Thu, 25 Sep 2025 13:40:01 GMT
 published on: 2025-09-22 09:13:20  newser.com Mon, 22 Sep 2025 14:13:20 GMT
 adagene inc. sponsored adr (nasdaq:adag) short interest update  MarketBeat Sat, 20 Sep 2025 00:26:39 GMT
 Adagene (ADAG) Gains New "Buy" Rating from Lucid Capital Markets  GuruFocus Thu, 18 Sep 2025 13:40:38 GMT
 Adagene initiated with a Buy at Lucid Capital  TipRanks Thu, 18 Sep 2025 07:00:00 GMT
 Lucid Capital Markets initiates coverage on Adagene stock with Buy rating  Investing.com India Thu, 18 Sep 2025 07:00:00 GMT
 Adagene Expands SAFEbody® Collaboration and License  GlobeNewswire Tue, 16 Sep 2025 12:11:22 GMT
 published on: 2025-09-10 02:28:14  Newser Wed, 10 Sep 2025 07:28:14 GMT
 adagene to present new adg126 clinical data at asco-gi  MSN Wed, 10 Sep 2025 06:20:55 GMT
 published on: 2025-09-10 00:05:16  Newser Wed, 10 Sep 2025 05:05:16 GMT
 published on: 2025-09-08 18:00:35  beatles.ru Mon, 08 Sep 2025 15:01:27 GMT
 is adagene (adag) stock outpacing its medical peers this year?  Yahoo Finance Mon, 08 Sep 2025 07:00:00 GMT
 published on: 2025-09-08 01:39:27  Newser Mon, 08 Sep 2025 06:39:27 GMT
 adagene to present new adg126 clinical data at asco-gi  MSN Sat, 06 Sep 2025 13:21:01 GMT
 Adagene’s ADG126 to be Highlighted in Two Presentations at  GlobeNewswire Fri, 05 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 01:30:08  Newser Thu, 04 Sep 2025 06:30:08 GMT
 former yervoy developer axel hoos joins adagene as advisor by investing.com  Investing.com Canada Thu, 04 Sep 2025 06:28:28 GMT
 Former YERVOY developer Axel Hoos joins Adagene as advisor  Investing.com Wed, 03 Sep 2025 07:00:00 GMT

Adagene Inc
(NASDAQ:ADAG) 

ADAG stock logo

Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its products include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the ...

Founded: 2011
CEO: Peter Luo  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends